J. Sato

发表

Farm village activation project on biofuel crops in Laos.

J. Sato, K. Intabon, T. Maekawa, 2015 .

Role of Pharmacometrics in Drug Development in the Pediatric Population

I. Yano, Hidefumi Nakamura, T. Fukuda, 2016 .

Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare Diseases

Anne R. Pariser, A. Gropman, A. Pariser, 2022, Therapeutic Innovation & Regulatory Science.

Study factors associated with the incompletion of clinical trials that include pediatric patients: a retrospective analysis of the European Clinical Trials Database and a lesson from the European region

Nanae Tanemura, H. Urushihara, J. Sato, 2021, Trials.

Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan

J. Sato, H. Malinowski, A. Westelinck, 2008, Journal of clinical pharmacology.

Real World Survey of Patient Engagement Status in Clinical Research: The First Input from Japan

Nanae Tanemura, H. Urushihara, J. Sato, 2020, The Patient - Patient-Centered Outcomes Research.

Pharmacokinetic-pharmacodynamic analysis of fluoroquinolones against Bacillus anthracis

T. Shibata, J. Sato, T. Kihira, 2004, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Standardizing Safety Assessment and Reporting for Neonatal Clinical Trials.

L. Fabbri, R. Portman, J. Davis, 2019, The Journal of pediatrics.

Achieving Regulatory Alignment for Anti-Infective Clinical Trials.

M. Cavaleri, S. Nambiar, J. Sato, 2020, ACS Infectious Diseases.

Evolving Vision of Regulatory Science in the Global Medical Community

J. Sato, Daisaku Sato, S. Sekine, 2020, Clinical pharmacology and therapeutics.

Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems

A. Saint‐Raymond, J. Sato, Y. Kishioka, 2020, Expert review of clinical pharmacology.

Family background and school continuation decisions in Japan

J. Sato, 1991 .